Showing posts with label Quality of Life. Show all posts
Showing posts with label Quality of Life. Show all posts

Monday, September 6, 2010

Moral of the story: The evidence continues to evolve as we learn more about Alzheimer's.  Mentally stimulating activity can delay onset, but once onset does occur, patients deteriorate most rapidly.

Source: AMA Morning Rounds 9/2/2010


Mentally stimulating activities may delay, not prevent, signs of Alzheimer's.

ABC World News (9/1, story 8, 0:30, Sawyer) reported, "There is a new study that found mentally stimulating activities," such as "reading and solving puzzles...can indeed delay the outset of Alzheimer's disease, but not prevent it for good."
        "Poring over crossword puzzles, reading, and listening to tunes may slow or delay brain decline at first, but being mentally active might speed up dementia once it hits," USA Today (9/2, Marcus) reports. According to Robert Wilson, PhD, of the Rush University Medical Center and the lead author of the study published online Sept. 1 in the journal Neurology, "The person who has had a more mentally stimulating lifestyle may have more signs of disease in his brain, but the brain has been able to compensate for it better." While "researchers don't fully understand why active-minded people suffer such a rapid decline once they develop Alzheimer's...the study shows the advantages of using your brain because of the early benefits."
        The Los Angeles Times (9/1, Healy) reported that in the "study of 1,157 Chicago-based seniors who were followed for an average of just over 11 years," investigators found that "the steepest downward trajectories belonged to those who had been diagnosed with Alzheimer's disease, but who had reported high levels of mental engagement at the outset of the study." Meanwhile, "fellow Alzheimer's sufferers who had not sought out much intellectual stimulation at the study's outset showed a more gradual decline in their function."
        The Washington Post (9/1, Stein) "The Checkup" blog reported that, according to Wilson, "those who have been mentally active are able to maintain their thinking abilities despite whatever damage is occurring in their brains for much longer than those who are not," probably because they have achieved some cognitive reserve. Therefore, "when the damage finally does get so bad that it starts to show itself, these people are actually much farther along and so go downhill much more quickly."
        The CNN (9/1, Landau) "The Chart" blog reported, "That's not necessarily a bad thing, if you consider quality of life issues, researchers say." The blog entry quoted Wilson as saying, "At the end of the day, you spend less of your lifespan in that demented state."
        HealthDay (9/1, Phillips) noted, "According to the authors, the results suggest that mental exercises help prevent the onset of dementia, but only if they're started before signs of cognitive impairment appear -- after that point, the brain is probably too damaged for such interventions to make a difference."
        New discovery reveals potential Alzheimer's medication target. The New York Times (9/2, A25, Kolata) reports that a discovery made by scientist Paul Greengard, PhD, appears to reveal "a new potential drug target that...could slow or halt the devastating effects" of Alzheimer's disease, according to research published in the journal Nature. Greengard has discovered what he calls the gamma secretase activating protein (GSAP), which tells gamma secretase to make produce beta amyloid. Working with genetically engineered mice, Greengard "blocked the gene for" GSAP. Notably, those mice stayed healthy and did not go on to develop beta-amyloid brain plaques that are characteristic in Alzheimer's disease.
        The CNN (9/1, Willingham) "The Chart" blog reported that modified forms of the medication Gleevec (imatinib mesylate), used to treat certain forms of leukemia and gastrointestinal cancers, have "the ability to bind" to GASP and even reduce "beta-amyloid production." Unfortunately, Gleevec "does not cross the blood-brain barrier," but researchers believe that it will someday be possible to create medications that "target GSAP, but do not have that limitation."

Tuesday, August 10, 2010

Parents' skewed weight perception of their children contributing to rising obesity rates

Moral of the story: Every parents believes their kids are perfect. Get real.  1/3 are too fat.

Source: AMA Morning Rounds 7/2/2010


Parents' skewed weight perception of their children contributing to rising obesity rates.

Claudia Kalb wrote in Newsweek (7/1) that a report by the Trust for America's Health and the Robert Wood Johnson Foundation "finds that the majority of Americans believe that childhood obesity is a 'significant and growing challenge for the country,' and yet 84 percent say their children are at a healthy weight -- despite national stats showing that nearly one third of children and teens are overweight...or obese." Although "Americans understand there's a problem," they "don't think their kids are a part of it" -- a "well-known phenomenon in the research world." But, research has also shown that "only seven percent of parents recalled ever being told that their child was gaining weight too fast or was overweight." Kalb concluded that "patients are listening. It's never too soon to start educating them."

Saturday, August 7, 2010

Prolonged sitting may increase mortality risk, regardless of daily exercise.



Moral of the story: take breaks if you sit at a desk all day, watch less TV, be more active


Source: AMA Morning Rounds 6/23/2010

Prolonged sitting may increase mortality risk, regardless of daily exercise.


The CNN (7/22) "The Chart" blog reported that a paper appearing in the American Journal of Epidemiology reveals that "people who spend more time sitting during their leisure time have an increased risk of death, regardless of daily exercise." In fact, after following some 123,000 healthy adults, American Cancer Society researchers "found women who spend over six hours a day sitting during leisure time (watching TV, playing games, surfing the web, reading) were 40 percent more likely to die sooner than women who spend less than three hours sitting," while "men...have a 20 percent increased risk of death." Investigators say that "prolonged time sitting suppresses" the immune system and may increase "resting blood pressure and cholesterol levels."

Thursday, May 27, 2010

Physical activity or medical treatment

Moral of the story: Which do we target in health campaigns? Why not both?

Source: BMJ

(1) What's more important in the obesity battle – physical activity or medical treatment?
(Head to Head: Should health policy focus on physical activity rather than obesity?)
Yes: http://www.bmj.com/cgi/content/extract/340/may25_1/c2603 No: http://www.bmj.com/cgi/content/extract/340/may25_1/c2602
Experts disagree on bmj.com today about the best way to tackle the obesity crisis. While Professor Louise Baur and colleagues from the Children's Hospital at Westmead and the University of Sydney in Australia acknowledge that "physical inactivity is a major contributor to the global burden of disease," they says that it would be wrong to only focus on this and ignore the problem of obesity.
Baur and colleagues argue that physical inactivity is just one marker and that there is substantial evidence that unhealthy diets low in fibre and high in sugar and large portion size are also responsible for obesity and the diseases associated with it.
However, Dr Richard Weiler, a specialist registrar in sport and exercise medicine at Imperial College Healthcare NHS Trust and general practitioner, and colleagues believe that inadequate cardio-respiratory fitness causes disease more than excess body fat, waist size and body mass index.
Weiler and colleagues maintain that "physical inactivity is one of the greatest health threats facing developed nations today" and they are concerned that 95% of the populations in England and the United States do not meet the recommended guidelines of doing 30 minutes moderate to vigorous physical activity on at least five days a week or equivalent.
They say this is alarming given that physical inactivity rather than obesity per se is an actual cause for many illnesses including obesity, heart disease, type 2 diabetes, mental health problems, high blood pressure and dementia.
Spending huge amounts on treating obesity is not the right way forward, they argue. Weight loss drugs and surgery are risky and the long-term benefits are limited and they certainly do not have the associated health benefits linked to physical activity. They conclude that it is time for health policy and healthcare professionals to focus on fighting physical inactivity, a "chronic disease that has an adult population prevalence of 95%."
Professor Baur, on the other hand, believes that "on its own, improving physical activity will have little impact on reducing overall levels of already established obesity."
She believes that obese people need access to high quality treatment provided by well-trained professionals to deal with their weight and any linked health problems.
In conclusion, Professor Baur and colleagues advocate tackling obesity with a range of strategies, for example, increasing physical activity, improving diet and lifestyles. They say urban planning should be developed to encourage people to use their car less and cycle more and public transport should be made more accessible and affordable.
Contacts:
Louise Baur, The Children's Hospital at Westmead, Sydney, NSW, Australia
Email: louiseb3@chw.edu.au Richard Weiler, Specialist Registrar in Sport and Exercise Medicine, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK and General Practitioner, Hertfordshire Email: c/- cassie.zachariou@imperial.nhs.uk

Monday, May 24, 2010

Pill for female sex drive

Moral of the story: a possibly unnecessary an dangerous drug that targets female arousal.

Source: AMA Morning Rounds 5/24/2010

FDA advisory committee to consider approving pill designed to boost women's sex lives.
The Washington Post (5/24, Stein) reports, "A panel of federal advisers will soon" consider "endorsing the first pill designed to do for women what Viagra [sildenafil] did for men: boost their sex lives." The drug known as "flibanserin," which was developed by Germany's Boehringer Ingelheim, may become "the first prescription medication to tap what some have estimated could be a $2 billion market in the United States alone." But, "even before the FDA's Reproductive Health Drugs Advisory Committee meets June 18 to consider the request, the prospect of the drug's approval has triggered debate over whether the medication, like others in the pipeline, represents a long-sought step toward equity for women's health or the latest example of the pharmaceutical industry fabricating a questionable disorder to sell unnecessary -- and potentially dangerous -- drugs."
The creator of a new documentary on "female sexuality" stumbled upon the issue while researching her film, Newsweek (5/23, Kantrowitz, Wingert) reported. Liz Canner "was bewildered by the purported disease" that some refer to as "female sexual dysfunction." Noting that Vivus executives told her that "43 percent of women had this disorder," Canner asked, "How could that be true if I had never heard of it before?" After "a cross-country quest that included visits with scientists, experts in erotica, and individual women," Canner "ultimately concluded that the catch-all female sexual dysfunction is essentially a phony disease made up by pharmaceutical companies."



- Posted using BlogPress from my iPhone

Monday, March 29, 2010

active surveillance for large numbers of prostate cancer patients

Moral of the story: With prostate screening methods being pretty crummy, people are finally starting to realize that low grade prostate cancer might be better treated (at least at first) simply with a watch and wait protocol. Biopsy and surgery have risks, which may be able to be postponed indefinitely.

Source: AMA Morning Rounds 3/29/2010

Major medical organization endorses active surveillance for large numbers of prostate cancer patients.


The Chicago Tribune (3/28, Graham) reported that "for the first time," active surveillance is "being endorsed for large numbers of men by a major medical organization: the National Comprehensive Cancer Network, an alliance of 21 leading cancer centers across the US." According to "new guidelines," the approach is recommended "for men deemed to have 'very low risk' prostate cancer and a life expectancy of less than 20 years," as well as for those men whose "prostate cancer is considered 'low risk' and" have a "life expectancy" of "less than 10 years." In other words, "almost 40 percent of the 192,000 men diagnosed with prostate cancer each year could qualify for active surveillance under those standards, said Dr. James Mohler," part of the "committee that prepared the guidelines."
        Researchers in Illinois conducting active surveillance studies. The Chicago Tribune (3/28, Graham) reported that last year, NorthShore University Health System began "recruiting men who are at least 60 years old with low-grade prostate cancer (Gleason score of 6 or less) and relatively low PSA scores (less than 10)" to find out which patients "can be managed safely with active surveillance." Adhering to "a slightly different protocol," University of Chicago researchers are also "tracking about 50 men with low-grade, low-risk prostate cancers." Meanwhile, a third trial, in which University of Toronto researchers "examined 453 men undergoing active surveillance over a period of up to 13 years," revealed that "men's risk of dying from prostate cancer during the study was one percent, while their risk of dying from another condition was 16 times as high," according to results "presented last year at meetings of the American Society of Clinical Oncology."

Sunday, March 21, 2010

New reports suggest many Americans are being overtreated

Moral of the story: Americans are overtreated and this is both dangerous and costly.  People need to understand that more expensive and more intesive care is NOT better care.

Source: AMA Morning Rounds 3/15/2010

New reports suggest many Americans are being overtreated.


The AP (3/13, Tanner) reported, "A spate of recent reports suggests that many Americans are being overtreated." Research appearing in the New England Journal of Medicine "suggested that too many patients are getting angiograms...who don't really need them; and specialists convened by the National Institutes of Health said doctors are too often demanding repeat cesarean deliveries for pregnant women after a first C-section." Meanwhile, "the American Cancer Society cast more doubt on routine PSA tests for prostate cancer" as "experts dispute how much routine cancer screening saves lives." Still, "Not all doctors and advocacy groups agree with the criticism of screening. Many argue that it can improve survival chances and that saving even a few lives is worth the cost of routinely testing tens of thousands of people."

Hearing aid with no externally visible components receives FDA approval.

Moral of the story: A hearing aid no one else can see.  cool. necessary?

Source: AMA Morning Rounds 3/18/2010


Hearing aid with no externally visible components receives FDA approval.


The Los Angeles Times (3/17, Healy) "Booster Shots" blog reported, "For several decades, people with hearing loss due to noise, viral infections or aging have had hearing aids to help maintain an aural tie to the world." Now, after a receiving approval from the FDA, "these patients will" have access to "a surgically implantable hearing system called Esteem." What's more, the "new device is considered to be the first hearing aid that has no externally visible components."

Sunday, November 29, 2009

Public health impact of strategies to reduce greenhouse gas emissions

Moral of the story: The WHO and others are looking at how the different strategies will affect the health of the public. Overall, it is likely to improve health (and drive down health care costs).

Source: WHO, http://www.who.int/globalchange/news/2009/greenhouse_25112009/en/index.html

25 November 2009
London and Washington D.C.

Public health impact of strategies to reduce greenhouse gas emissions

Different mitigation strategies are likely to have different implications for health. For example, how much would a move to low carbon sources of power improve public health by reducing air pollution? What could be the health benefits of encouraging people to cycle and walk rather than take the car? Could improved biomass cook stoves in developing countries have impacts on child and maternal health as well as greenhouse gas emissions?

In the first major study of its kind, an international team of researchers in collaboration with WHO, have been modelling the health effects of different policies to reduce greenhouse gas emissions in high and low-income countries. Case studies focus on four key sectors: power generation, transport, household energy, and food and agriculture. The study findings will be published in a special issue in the Lancet in November 2009.

The results were launched at events in London and Washington on 25 November 2009.

Related links

- Dr Margaret Chan, editorial - Cutting Carbon, Improving Health [pdf 91kb]

- The Health benefits of tackling climate change
An executive summary for the Lancet series

- The Wellcome Trust

- The London School of Hygiene & Tropical Medicine

Scientists find link between gut microbiota, diet, and weight gain.

Moral of the story: What you eat matters. A lot. The link between diet and weight is rather complicated and taking out fats and sugars can help to change the fauna of your stomach to help you lose weight. Chewing gum and breastfeeding help shed pounds too.

Source: AMA Morning Rounds 11/12/09

Scientists find link between gut microbiota, diet, and weight gain.

The Los Angeles Times (11/12, Maugh) reported, "A high-fat, high-sugar diet does more than pump calories into your body. It also alters the composition of bacteria in your intestines, making it easier to gain weight and harder to lose it," according to a new paper in Science Translational Medicine. What's more, the "changeover can happen in as little as 24 hours."

Technically known "as the gut microbiota," intestinal "microbes perform a vast range of vital functions, including helping to regulate the calories the body obtains from food and stores as fat," according to Time (11/12, Park). Through earlier experiments, however, Washington University researchers found that the "gut microbiota of obese mice...have significantly more of one main type of bacteria called Firmicutes, and fewer of another kind called Bacteroidetes (both types populate human guts as well); in normal mice, the distribution is the opposite." With that in mind, the team devised a new study in which human microbiota was used "to colonize mice guts." The rodents were then fed "equivalents of typical human diets to see how their microbes -- and their weight -- might change."

Lead investigator Dr. Jeffrey I. Gordon told HealthDay (11/11, Gordon) that when his team "switched these humanized animals [from a low-fat] to a junk-food diet, high in fat with lots of simple sugars, the structure of the microbial community changed dramatically and very rapidly." What's more, the mice "became obese on Western diets." Investigators also discovered that "the microbiota passes from generation to generation."

Study points to chewing gum as weight loss aid. The Washington Post (11/11, Huget) reports that for anybody trying to lose weight, "taking up gum-chewing might not be a bad idea," as "there's actually a bit of scientific evidence showing that chewing gum helps fight fat in a number of ways." The research, sponsored by the Wrigley Science Institute, has suggested "that chewing gum may help reduce cravings, particularly for sweet snacks, and spur people to cut their daily intake by about 50 calories." The findings were presented at the annual scientific meeting of the Obesity Society last month, and "showed that gum-chewing people consumed 67 fewer calories at lunch and didn't compensate by eating more later in the day."

Breastfeeding's effect on postpartum weight discussed. The New York Times (11/12, E3, Louis) reports, "That breastfeeding gives mothers an edge shedding baby weight has long been suspected." A Danish study published last year showed that "the more a mother breast-feeds, the less weight she retains six months after birth." But, other research has shown that "breast-feeders don't necessarily shed fat quicker than women who feed their newborns formula." Meanwhile, "a small double-blind randomized study conducted at Cincinnati Children's Hospital Medical Center found that non-lactating women lost more body fat than lactating women at six months, and at a faster rate." Still, "others suggest that women who view breast-feeding as a dieting tool may have 'deeper body issues.'" One expert said "she was troubled by our cultural preoccupation with postpartum weight."

Depression may take as many years off life as smoking.

Moral of the story: Mental illnesses are serious threats to long-term health

Source: AMA Morning Rounds 11/24/09

Depression may take as many years off life as smoking.

HealthDay (11/23, Dotinga) reported that, according to a study published in the British Journal of Psychiatry, "being depressed might take as many years off your life as smoking does." After "analyzing death records and a survey of more than 60,000 people," researchers at King's College London found that "during the four years after the survey, the death rate was higher among those who'd appeared to be depressed, based on the survey findings, than among the others," with the "increase...about as high as that among smokers." Notably, the investigators also found that "a combination of depression and anxiety appears to be better for longevity than just depression."

Friday, November 20, 2009

Spray-on anesthetic helps delay ejaculation.

Moral of the story: One of those awkward doorknob questions just got a better answer.

Source: AMA Morning Rounds 11/20/09

Bloomberg News (11/20, Matsuyama) reports, "A spray-on treatment for premature ejaculation may prolong sexual intercourse by as much as five times." In fact, the drug, known as PSD502, "delayed orgasm by an average of 108 seconds" after one month of treatment, according to a 256-patient trial conducted in Canada, Poland, and the US.

The work may benefit the estimated "one in three US men ages 18 to 59" who have dealt with the problem at one time or another, according to the Los Angeles Times (11/19, Maugh) "Booster Shots" blog. That's "about twice as many as those who suffer from erectile dysfunction." Indeed, "some antidepressant-like drugs, such as dapoxetine, have been approved in a few countries to treat the condition, but the Food and Drug Administration rejected it because of long-term side effects." And while "some physicians prescribe anesthetic creams like EMLA cream...off-label," they "require 45 minutes to work."

Now, researchers at the University of California-San Francisco may have stumbled upon a solution. According to WebMD (11/19, DeNoon), the spray "contains the anesthetics lidocaine and prilocaine," but it "doesn't deaden feeling, thanks to an ingredient in the spray that allows it to rapidly penetrate the skin." What's more, it "seems safe for men's female sex partners," as "only about 0.5% of female partners report decreased feeling in the vagina."

In light of those findings, HealthDay (11/19, Preidt) pointed out, "Sciele Pharma plans to seek US Food and Drug Administration approval of the spray." Reuters (11/20), the UK's Telegraph (11/19), and the UK's Press Association (11/19) also covered the story.

Monday, June 15, 2009

Alcohol’s Good for You? Some Scientists Doubt It

Moral of the story- Correlation is not causation. Writing from Guatemala there is little time to expand upon this excellent story, but read it! You may change your mind about "needing" that glass of wine and instead go for a walk or run.

http://www.nytimes.com/2009/06/16/health/16alco.html?ref=health

From the New York Times-
Published: June 15, 2009

By now, it is a familiar litany. Study after study suggests that alcohol in moderation may promote heart health and even ward off diabetes and dementia. The evidence is so plentiful that some experts consider moderate drinking — about one drink a day for women, about two for men — a central component of a healthy lifestyle.

But what if it’s all a big mistake?

For some scientists, the question will not go away. No study, these critics say, has ever proved a causal relationship between moderate drinking and lower risk of death — only that the two often go together. It may be that moderate drinking is just something healthy people tend to do, not something that makes people healthy.

“The moderate drinkers tend to do everything right — they exercise, they don’t smoke, they eat right and they drink moderately,” said Kaye Middleton Fillmore, a retired sociologist from the University of California, San Francisco, who has criticized the research. “It’s very hard to disentangle all of that, and that’s a real problem.”

Some researchers say they are haunted by the mistakes made in studies about hormone replacement therapy, which was widely prescribed for years on the basis of observational studies similar to the kind done on alcohol. Questions have also been raised about the financial relationships that have sprung up between the alcoholic beverage industry and many academic centers, which have accepted industry money to pay for research, train students and promote their findings.

“The bottom line is there has not been a single study done on moderate alcohol consumption and mortality outcomes that is a ‘gold standard’ kind of study — the kind of randomized controlled clinical trial that we would be required to have in order to approve a new pharmaceutical agent in this country,” said Dr. Tim Naimi, an epidemiologist with the Centers for Disease Control and Prevention.

Even avid supporters of moderate drinking temper their recommendations with warnings about the dangers of alcohol, which has been tied to breast cancer and can lead to accidents even when consumed in small amounts, and is linked with liver disease, cancers, heart damage and strokes when consumed in larger amounts.

“It’s very difficult to form a single-bullet message because one size doesn’t fit all here, and the public health message has to be very conservative,” said Dr. Arthur L. Klatsky, a cardiologist in Oakland, Calif., who wrote a landmark study in the early 1970s finding that members of the Kaiser Permanente health care plan who drank in moderation were less likely to be hospitalized for heart attacks than abstainers. (He has since received research grants financed by an alcohol industry foundation, though he notes that at least one of his studies found that alcohol increased the risk of hypertension.)

“People who would not be able to stop at one to two drinks a day shouldn’t drink, and people with liver disease shouldn’t drink,” Dr. Klatsky said. On the other hand, “the man in his 50s or 60s who has a heart attack and decides to go clean and gives up his glass of wine at night — that person is better off being a moderate drinker.”

Health organizations have phrased their recommendations gingerly. The American Heart Association says people should not start drinking to protect themselves from heart disease. The 2005 United States dietary guidelines say that “alcohol may have beneficial effects when consumed in moderation.”

The association was first made in the early 20th century. In 1924, a Johns Hopkins biologist, Raymond Pearl, published a graph with a U-shaped curve, its tall strands on either side representing the higher death rates of heavy drinkers and nondrinkers; in the middle were moderate drinkers, with the lowest rates. Dozens of other observational studies have replicated the findings, particularly with respect to heart disease.

“With the exception of smoking and lung cancer, this is probably the most established association in the field of nutrition,” said Eric Rimm, an associate professor of epidemiology and nutrition at the Harvard School of Public Health. “There are probably at least 100 studies by now, and the number grows on a monthly basis. That’s what makes it so unique.”

Alcohol is believed to reduce coronary disease because it has been found to increase the “good” HDL cholesterol and have anticlotting effects. Other benefits have been suggested, too. A small study in China found that cognitively impaired elderly patients who drank in moderation did not deteriorate as quickly as abstainers. A report from the Framingham Offspring Study found that moderate drinkers had greater mineral density in their hipbones than nondrinkers. Researchers have reported that light drinkers are less likely than abstainers to develop diabetes, and that those with Type 2 diabetes who drink lightly are less likely to develop coronary heart disease.

But the studies comparing moderate drinkers with abstainers have come under fire in recent years. Critics ask: Who are these abstainers? Why do they avoid alcohol? Is there something that makes them more susceptible to heart disease?

Some researchers suspect the abstainer group may include “sick quitters,” people who stopped drinking because they already had heart disease. People also tend to cut down on drinking as they age, which would make the average abstainer older — and presumably more susceptible to disease — than the average light drinker.

In 2006, shortly after Dr. Fillmore and her colleagues published a critical analysis saying a vast majority of the alcohol studies they reviewed were flawed, Dr. R. Curtis Ellison, a Boston University physician who has championed the benefits of alcohol, hosted a conference on the subject. A summary of the conference, published a year later, said scientists had reached a “consensus” that moderate drinking “has been shown to have predominantly beneficial effects on health.”

The meeting, like much of Dr. Ellison’s work, was partly financed by industry grants. And the summary was written by him and Marjana Martinic, a senior vice president for the International Center for Alcohol Policies, a nonprofit group supported by the industry. The center paid for tens of thousands of copies of the summary, which were included as free inserts in two medical journals, The American Journal of Medicine and The American Journal of Cardiology.

In an interview, Dr. Ellison said his relationship with the industry did not influence his work, adding, “No one would look at our critiques if we didn’t present a balanced view.”

Dr. Fillmore and the co-authors of her analysis posted an online commentary saying the summary had glossed over some of the deep divisions that polarized the debate at the conference. “We also dispute Ellison and Martinic’s conclusions that more frequent drinking is the strongest predictor of health benefits,” they wrote.

(Dr. Fillmore has received support from the Alcohol Education and Rehabilitation Foundation of Australia, a nonprofit group that works to prevent alcohol and substance abuse.)

Dr. Ellison said Dr. Fillmore’s analysis ignored newer studies that corrected the methodological errors of earlier work. “She threw out the baby with the bathwater,” he said.

Meanwhile, two central questions remain unresolved: whether abstainers and moderate drinkers are fundamentally different and, if so, whether it is those differences that make them live longer, rather than their alcohol consumption.

Dr. Naimi of the C.D.C., who did a study looking at the characteristics of moderate drinkers and abstainers, says the two groups are so different that they simply cannot be compared. Moderate drinkers are healthier, wealthier and more educated, and they get better health care, even though they are more likely to smoke. They are even more likely to have all of their teeth, a marker of well-being.

“Moderate drinkers tend to be socially advantaged in ways that have nothing to do with their drinking,” Dr. Naimi said. “These two groups are apples and oranges.” And simply advising the nondrinkers to drink won’t change that, he said.

Some scientists say the time has come to do a large, long-term randomized controlled clinical trial, like the ones for new drugs. One approach might be to recruit a large group of abstainers who would be randomly assigned either to get a daily dose of alcohol or not, and then closely followed for several years; another might be to recruit people who are at risk for coronary disease.

But even the experts who believe in the health benefits of alcohol say this is an implausible idea. Large randomized trials are expensive, and they might lack credibility unless they were financed by the government, which is unlikely to take on the controversy. And there are practical and ethical problems in giving alcohol to abstainers without making them aware of it and without contributing to accidents.

Still, some small clinical trials are already under way to see whether diabetics can reduce their risk of heart disease by consuming alcohol. In Boston, researchers at Beth Israel Deaconess Medical Center are recruiting volunteers 55 and over who are at risk for heart disease and randomly assigning them to either drink plain lemonade or lemonade spiked with tasteless grain alcohol, while scientists track their cholesterol levels and scan their arteries.

In Israel, researchers gave people with Type 2 diabetes either wine or nonalcoholic beer, finding that the wine drinkers had significant drops in blood sugar, though only after fasting; the Israeli scientists are now working with an international team to begin a larger two-year trial.

“The last thing we want to do as researchers and physicians is expose people to something that might harm them, and it’s that fear that has prevented us from doing a trial,” said Dr. Sei Lee of the University of California, San Francisco, who recently proposed a large trial on alcohol and health.

“But this is a really important question,” he continued. “Because here we have a readily available and widely used substance that may actually have a significant health benefit — but we just don’t know enough to make recommendations.”

Wednesday, May 20, 2009

Study finds volunteering decreases mortality risk among retired

Moral of the story: Start volunteering, it may save your life. This study looks at retirees and found volunteering has bidirectional affects with health. Not only is volunteering a sign of good health, it also improves health. Get yourself, your parents or your grandparents out there volunteering.

Study finds volunteering decreases mortality risk among retired

The Advisory Board Company
05/19/2009

Retirees older than age 65 who volunteer have a lower mortality risk than their non-volunteering peers, according to a study presented earlier this month at the American Geriatrics Society’s annual meeting in Chicago. Although previous research identified a link between volunteering and lower mortality rates, such studies involved individuals born before 1920 and failed to adjust the results for possible confounders, such as socioeconomic status and chronic health conditions. To assess the relationship when accounting for those variables, researchers from the University of California-San Francisco and Montefiore Medical Center examined 6,360 retired men and women older than age 65 who were enrolled in the Health and Retirement Study—considered representative of all U.S. adults—in 2002. Study subjects had an average age of 78, and 60% were female. Examining participants’ volunteerism patterns, the researchers found that 12% of participants who volunteered died, compared with 26% of non-volunteers. After adjusting the data for participants’ demographics, socioeconomic status, chronic health conditions, geriatric syndromes, functional limitations, self-rated health, depression, and cognition, the researchers found that the link “wasn’t as strong, but still existed.” Commenting on the study, one researcher notes that volunteering may be associated with self-efficacy—a belief in one’s own abilities to accomplish tasks—which helps individuals remain engaged in a healthy and active lifestyle (Gordon, HealthDay, 5/8).